Economy

Street Recommendation Roundup on Axon Enterprise, Inc. (:AAXN), Axsome Therapeutics, Inc. (:AXSM)

The company's shares closed yesterday at $4.60.

"Myrtle Potter is a recognized healthcare leader with extensive experience and unparalleled success in commercializing numerous innovative medicines", said Herriot Tabuteau, M.D., Chief Executive Officer and Chairman of the Board of Axsome. After starting her career with Procter and Gamble Patient Care Products, Ms. Potter went on to spend 14 years of her early career at Merck & Co. "While at Genentech, Ms. Potter led the commercialization of a long list of products: "Herceptin, Tarceva, Xolair, Avastin, Rituxan, Nutropin, Activase, and TNkase". It represents a security's price that, if achieved, results in a trader recognizing the best possible outcome for his investment.

At the end of 03/31/2017 reporting period, 25 institutional holders increased their position in Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders.

Now we look at the Moving Averages, the 200-day is -17.4, the 50-day is 15.42 and the 20-day is 13.09.

The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.10. The company's market cap is $107.27 Million. The stock's average true range of stands at 0.25, while the relative strength index is 67.2. (:AAXN). Analysts are projecting that the stock will reach $30.83 on a short term (1 year) basis.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Sports Perspectives and is the property of of Sports Perspectives. The correct version of this piece can be viewed at https://sportsperspectives.com/2017/06/20/axsome-therapeutics-axsm-buy-rating-reiterated-at-aegis.html.

Institutional investors now hold around $32 million or 32.9% in AXSM stock.

Looking forward, the company is expected to report earnings of $-0.34 per share for the current quarter. Geode Capital Management LLC raised its position in shares of Axsome Therapeutics by 9.8% in the first quarter. Inside the closing six months period the stock's performance declined -24.59% while overall yearly performance lost -27.44%. The short ratio in the company's stock is documented at 4.35 and the short float is around of 8.38%.

Axsome Therapeutics, Inc. (AXSM) has 23.32 Million shares outstanding and 14.25 Million shares were floated in market. The third largest holder is Royce & Associates Lp, which now holds $3.61 million worth of this stock and that ownership represents almost 3.37% of its market capitalization. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications.



Like this

Latest


20 June 2017
Champions Trophy triumph is a massive boost for Pakistan cricket, says Arthur
This was Pakistan's largest margin of victory, by runs, in 129 ODIs against India , surpassing their 159-run success at Delhi in 2005.

20 June 2017
Grenfell Tower: Adele meets firefighters for 'tea and a cuddle'
It comes as hundreds of those affected by the fire - which has killed at least 79 people - marched to the tower on Monday night. May has come under personal attack for failing to meet residents during her first visit to the site.

20 June 2017
Natus Medical Incorporated (NASDAQ:BABY) Broker Price Targets For The Coming Week
A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range. More notable recent Natus Medical Inc (NASDAQ:BABY) news were published by: Fool.com which released: "How Natus Medical Inc".

20 June 2017
13 transported as 3 vehicles, including small bus, collide on Highway 93
Troopers say a blue auto that was traveling north went into the southbound lane and hit the bus, which rolled onto its side. Colo. 93 was reopened in both directions about 3:45 p.m., according to the Colorado Department of Transportation.

20 June 2017
Uber CEO Travis Kalanick taking leave of absence
A company can be aggressive yet have strong values, said Joseph Holt, a business ethics professor at the University of Notre Dame. The report recommends a massive overhaul for the company accused of promoting a toxic "bro culture" under Kalanick's leadership.

20 June 2017
ValuEngine Downgrades Gold Standard Ventures Corp (GSV) to Sell
It represents a security's price that, if achieved, results in a trader recognizing the best possible outcome for his investment. To measure price-variation, we found GSV's volatility during a week at 9.55% and during a month it has been found around 6.57%.

20 June 2017
Special Counsel Expands Russia Probe To Include Trump, Reports Say
It says Mueller planned to interview top current and former intelligence officials about their interactions with Trump. The president has long vehemently denied any collusion with Moscow , either by himself or his associates.

20 June 2017
Chevy Bolt EV rated a Top Safety Pick by IIHS
The vehicle just missed out on being awarded a Top Safety Pick+ by the IIHS due to its headlights, which were rated as "Poor". The results come at a good time for GM, who just opened Chevy Bolt EV orders nationwide for deliveries in August .

20 June 2017
The Airain ltd Buys New Stake in CGI Group, Inc. (GIB)
The technology company reported $0.68 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by $0.01. It has underperformed by 91.03% the S&P500.The move comes after 8 months negative chart setup for the $87.88 million company.

20 June 2017
This Weeks Target Prices For Noble Corporation (NYSE:NE)
The market capitalization for the company is reported at $10.62 billion, while the P/E ratio yielded by the company was 0.00. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward.



Recommended